 |
 |
 |
 |
 |
 |
"Making pharmaceutical research more open could shave years off the time it takes to bring a new drug to market".
SGC's commitment to accelerating drug discovery is profiled by John Lorinc in the University of Toronto Magazine.
On Friday August 22nd, 2014, sixteen members of SGC at University of Toronto completed the ALS Ice Bucket Challenge outside the MaRS building (video here). As part of the challenge, SGC's Director, Aled Edwards nominated Takeda's General Manager Tetsu Maruyama. In a video released today, Dr Maruyama responded along with seven of his Takeda colleagues.
Takeda has been a partner of the consortium since 2012.
In addition to completing the Ice Bucket Challenge, SGC-Toronto has raised $1,200 for ALS Canada.
The Structural Genomics Consortium in Toronto hosted ChemNET's first Bootcamp for the 2013-2015 trainees.
ChemNET is an NSERC CREATE training program that provides Chemistry graduate students and post-doctoral fellows the opportunity to gain practical medicinal and biological chemistry experience developing chemical probes for epigenetic proteins in collaboration with the pharmaceutical industry. All of ChemNET's output is open access and will be placed in the public domain with no restrictions.
Faster Cures interviews SGC Director Aled Edward on their Innovators spotlight.
Aled Edwards: Carrying Out Open-Access Research in Structural and Chemical Biology
SGC Toronto will hold the “Histone methyltransferases; Structure, Mechanism and Inhibition” symposium in Toronto on Thursday August 21st, 2014. During this one-day epigenetics symposium ten renowned speakers will present their work on Protein Arginine Methyltransferases (PRMTs), Protein Lysine Methyltransferases (PKMTs) and related medicinal chemistry. This symposium is sponsored by ChemNet, an NSERC CREATE medicinal chemistry training programme in partnership with the SGC and the pharmaceutical industry.
For more details, please go to http://www.thesgc.org/symposia/toronto/MTase-2014
